Metraipolis › archive › dc_7aa99e73fe29

Pharmacodynamic evidence for tedizolid use in Mycobacterium avium lung disease — Europe PMC PMID:41552671

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41552671
DOI: 10.5588/ijtldopen.25.0487
License (as archived): solo-consultazione
Archived: 2026-11-06T22:32:21.601Z
SHA-256 of the archived text: ce5fcfc37061fd6297bb392684a9d89abb6820a445c53da6b3e93cfeded730c9
Stable URL of this page: https://metraipolis.com/documento/dc_7aa99e73fe29

How to cite

Pharmacodynamic evidence for tedizolid use in Mycobacterium avium lung disease — Europe PMC PMID:41552671 — Europe PMC (en), https://europepmc.org/article/MED/41552671 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7aa99e73fe29 (Metraipolis archive dc_7aa99e73fe29, sha256 ce5fcfc37061fd6297bb392684a9d89abb6820a445c53da6b3e93cfeded730c9)

BibTeX

@misc{dc7aa99e73fe29,
  title = {Pharmacodynamic evidence for tedizolid use in Mycobacterium avium lung disease — Europe PMC PMID:41552671},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41552671},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7aa99e73fe29; sha256 ce5fcfc37061fd6297bb392684a9d89abb6820a445c53da6b3e93cfeded730c9},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41552671. Agents can read the archived copy with the MCP tool read_document.